// company-profile

Jade Biosciences, Inc.

JBIO
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings107Insiders32
// api This Jade Biosciences, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 5 insiders purchased shares. Buying was led by DOBMEIER ERIC.

// 90-day insight

Over the last 90 days, Jade Biosciences, Inc. insiders bought $0 across 5 transactions with no open-market sales.

  • Most active insider: DOBMEIER ERIC with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Jade Biosciences, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$693.7M
QoQ change
+5.3%
Reporting period
2026-03-31
#1
FMR LLC
CIK 315066
$78.3M
5.6M shares
#2
Fairmount Funds Management LLC
CIK 1802528
$64.0M
4.6M shares
#3
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$51.6M
3.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 9, 2026DOBMEIER ERICJBIO
Award
34,843$0.00$0K
Jun 9, 2026Fairmount Funds Management LLCJBIO
Award
34,843$0.00$0K
Jun 9, 2026CAIN CHRISTOPHER W.JBIO
Award
34,843$0.00$0K
Jun 9, 2026Lavelle ErinJBIO
Award
34,843$0.00$0K
Jun 9, 2026Klein Lawrence OttoJBIO
Award
34,843$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.